Skip to main content
Signal8

Hodgson Ian

SEC insider (Form 3/4/5 filer). CIK 0002057525. Chief Operating Officer at Corbus Pharmaceuticals Holdings, Inc. (CRBP). 3 reported Form 4/5 transactions since Sep 2024; latest on Feb 17, 2026. Located in NORWOOD, MA.

Companies Hodgson Ian has filed insider reports for

  • Corbus Pharmaceuticals Holdings, Inc. (CRBP): Officer, Chief Operating Officer
Hodgson Ian profile photo

Hodgson Ian

CIK: 0002057525

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (66.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Corbus Pharmaceuticals Holdings, Inc. logo
CRBP

Corbus Pharmaceuticals Holdings, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Corbus Pharmaceuticals Holdings, Inc. logo
    CRBP

    Corbus Pharmaceuticals Holdings, Inc.

    Feb 17, 2026
    Sale
    Direct
    847 shares at avg. $7.38$6K
  • Corbus Pharmaceuticals Holdings, Inc. logo
    CRBP

    Corbus Pharmaceuticals Holdings, Inc.

    Feb 3, 2026
    Sale
    Direct
    2.4K shares at avg. $8.09$20K
  • Corbus Pharmaceuticals Holdings, Inc. logo
    CRBP

    Corbus Pharmaceuticals Holdings, Inc.

    Jan 14, 2026
    Award
    Direct
    28.4K shares-

1-3 of 3